ZoomerMedia Announces New CFO
TORONTO, March 08, 2024 (GLOBE NEWSWIRE) — Moses Znaimer, Founder and CEO, ZoomerMedia Limited (TSXV: ZUM) (“ZoomerMedia” or the “Company”), […]
Eguana Arranges Short-Term Financing
CALGARY, Alberta, March 08, 2024 (GLOBE NEWSWIRE) — Eguana Technologies Inc. (TSXV: EGT) (OTCQB: EGTYF) (“Eguana” or the “Company”), a […]
TRILLION ENERGY ANNOUNCES CFO AND DIRECTOR CHANGE
Vancouver, B.C., March 08, 2024 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company”) (CSE: TCF) (OTCQB: TRLEF) […]
AMREP Reports Third Quarter Fiscal 2024 Results
HAVERTOWN, Pa., March 08, 2024 (GLOBE NEWSWIRE) — AMREP Corporation (NYSE:AXR) today reported net income of $92,000, or $0.02 per […]
ThreeD Capital Inc. Announces Unaudited February 29, 2024 Net Asset Value Per Share – $0.85
TORONTO, March 08, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture […]
iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company […]
NN Announces First Steps in Balance Sheet Optimization Plan
CHARLOTTE, N.C., March 08, 2024 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and […]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., March 08, 2024 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing […]
Landsea Homes Announces Closing of Secondary Common Stock Offering
DALLAS, March 08, 2024 (GLOBE NEWSWIRE) — Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”), a publicly traded […]
PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
VANCOUVER, British Columbia, March 08, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), […]
